Open-House Drug Rebate Agreements pursuant to § 130a para. 8c SGB V for the KV Region Brandenburg

… Health Fund, acting as a regional association (§ 36 KVLG 1989), the KNAPPSCHAFT Regional Directorates Cottbus represented by the head office in Bochum, act as a regional association (§ 212(3) SGB V), as well as the replacement funds the Techniker Krankenkasse (TK), the BARMER, the DAK - Gesundheit, the Kaufmännische Krankenkasse - KKH, the HEK - Hanseatic Health Fund, the Handelskrankenkasse (hkk), Bremen intend to conclude non-exclusive discount agreements with all interested pharmaceutical companies pursuant to § 130a(8) SGB V for parenteral preparations of finished medicinal products manufactured in pharmacies in the oncology for immediate medical application to patients in the Brandenburg region. The AOK Northeast. The health insurance company is authorized to conclude these discount agreements, to terminate them and to take other actions necessary in the context of the open house procedure. The clients offer all interested pharmaceutical companies that meet the eligibility requirements listed below the conclusion of identical and non-individually negotiable discount agreements. The earliest possible start date is 01.05.2026, all contracts end on 30.04.2027. The offer must be submitted at the beginning of the contract by 01.05.2026 at the latest by 21.03.2026. For a later start of the contract, the deadline for the submission of tenders is the 21st of the respective month for a start of the contract at the LAST FIRST month (example: Contract start 01.06.2026; Deadline for submission of tenders: 21.04.2026). A contract can be concluded at any time during this term, but at the latest on 21.02.2026. The contracts can be terminated with a notice period of eight weeks to the end of the month. Upon the entry into force of a rebate agreement for medicinal products with the active substance covered by the contract for the region of Brandenburg concluded by a federal or state-specific, open procedure, the open-house agreements shall automatically cease to apply for the corresponding period. A contract is concluded with all interested pharmaceutical companies who prove their suitability by means of a completed and signed self-declaration of reliability. The pharmaceutical entrepreneur must submit the completed and signed contract (the signatory's right of representation must be derived from the extract from the commercial register, otherwise a power of attorney must be submitted) together with the completed file "OHV _8c _Brandenburg _Determination _[active substance name] _PZN" as well as the completed and signed self-declaration of reliability. The documents can be submitted in WRITING form by hand or with the qualified electronic signature. For more information, please refer to the "Procedural Information" form. The file "OHV _8c _Brandenburg _Determination _[active substance name] _PZN" shall be transmitted electronically. Documents signed by hand in WRITING form must be sent in duplicate in their original form to the following address: by post: A